Sign in to view content

Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy: An Anchored Matching-Adjusted Indirect Comparison of the Phase 3 Trials

Paul Hahn, MD, PhD, FASRS

Video
Published 2023

Related

Accuracy of Diagnosis Codes for Patients With Concurrent Geographic Atrophy and Exudative Age-Related Macular Degeneration
Jong G Park, MD
Annual Meeting Talks
2023
Avacincaptad Pegol, A Novel C5 Inhibitor, Demonstrates Continued Reduction in Geographic Atrophy Growth: 18-Month Results From GATHER1 Clinical Trial
Jason Hsu, MD
Annual Meeting Talks
2021
Assessment of Progression of Geographic Atrophy in the FILLY Study
David R Lally, MD
On Demand Cases, Courses, and Papers
2020

Category: AMD-Non-Neovascular

See more